ResMed, Inc. Share Price
Stocks
RMD
US7611521078
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
NYSE
21:00:02 10/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 234.11 USD | -0.69% |
|
+3.10% | -2.81% |
| Market Cap | 32.93B 29.53B 27.22B 24.72B 46.78B 3,087B 48.08B 326B 130B 1,654B 124B 121B 5,229B | P/E 2027 * |
19.6x | P/E 2028 * | 18x |
|---|---|---|---|---|---|
| Enterprise Value | 32.03B 28.73B 26.48B 24.04B 45.51B 3,004B 46.78B 317B 126B 1,609B 120B 118B 5,087B | EV / Sales 2027 * |
5.49x | EV / Sales 2028 * | 5.07x |
| Free-Float |
73.23% | Yield 2027 * |
1.14% | Yield 2028 * | 1.22% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RMD | Delayed | |
CBOE
| RMD | Real-time | |
|
London S.E.
| 0KW4 | Delayed | |
|
Berne S.E.
| RME | End-of-day quote | |
|
Mexican S.E.
| RMD * | End-of-day quote | |
|
Deutsche Boerse AG
| RME | Delayed | |
|
Tradegate
| RME | Real-time | |
|
Börse Stuttgart
| RME | Delayed | |
|
Wiener Boerse
| RMD | End-of-day quote | |
|
Boerse Muenchen
| RME | Real-time | |
|
Borsa Italiana
| 1RMD | End-of-day quote | |
|
Xetra
| RME | Delayed |
Last Transcript: ResMed, Inc.
| 1 day | -0.69% | ||
| 1 week | +3.10% | ||
| Current month | +1.81% | ||
| 1 month | +1.76% | ||
| 3 months | +6.39% | ||
| 6 months | +13.23% | ||
| Current year | -2.81% |
| 1 week | 231.13 |  | 246.68 |
| 1 month | 221.59 | | 255.56 |
| Current year | 180.26 | | 277.67 |
| 1 year | 180.26 | | 277.67 |
| 3 years | 140.81 | | 293.81 |
| 5 years | 132.24 | | 293.81 |
| 10 years | 57.45 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 54 | 28/02/2013 |
Aaron Bloomer
DFI | Director of Finance/CFO | 41 | 03/05/2026 |
| Chief Tech/Sci/R&D Officer | - | 31/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 31/12/2004 |
Mick Farrell
CHM | Chairman | 54 | 24/01/2023 |
Peter Farrell
CHM | Chairman | 84 | 31/05/1989 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/10/26 | Sell | General Counsel | -400 | 0.0003% | ||
| 07/10/26 | Exercice | Chief Executive Officer | 14,973 | 0.0104% | ||
| 08/09/26 | Exercice | Chief Executive Officer | 14,973 | 0.0104% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.69% | +3.10% | -6.39% | +63.03% | 32.93B | |
| -0.48% | +2.84% | +24.61% | +60.16% | 266B | |
| +0.42% | +2.61% | +11.81% | +19.85% | 166B | |
| -2.28% | +2.11% | -21.90% | +62.18% | 156B | |
| +1.54% | +2.76% | -55.70% | -13.30% | 64.79B | |
| -0.67% | +9.27% | +23.70% | +61.98% | 59.81B | |
| +0.71% | -0.95% | -0.97% | -9.81% | 53.3B | |
| -1.27% | +1.38% | +21.54% | +63.99% | 50.15B | |
| -0.28% | +0.77% | +3.31% | +85.09% | 49.47B | |
| -0.25% | +3.40% | +26.28% | +85.81% | 46.72B | |
| Average | -0.33% | +3.08% | +2.63% | +47.90% | 95B | |
| Weighted average by Cap. | -0.46% | +3.00% | +5.41% | +47.42% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 5.83B 5.23B 4.82B 4.38B 8.28B 547B 8.51B 57.69B 22.99B 293B 21.88B 21.42B 926B | 6.21B 5.56B 5.13B 4.66B 8.81B 582B 9.06B 61.41B 24.47B 312B 23.29B 22.79B 985B |
| Net income | 1.69B 1.52B 1.4B 1.27B 2.4B 158B 2.47B 16.73B 6.67B 84.92B 6.34B 6.21B 268B | 1.81B 1.63B 1.5B 1.36B 2.58B 170B 2.65B 17.96B 7.16B 91.17B 6.81B 6.67B 288B |
| Net Debt | -895M -802M -739M -671M -1.27B -83.87B -1.31B -8.85B -3.53B -44.94B -3.36B -3.29B -142B | -1.48B -1.33B -1.22B -1.11B -2.11B -139B -2.16B -14.66B -5.84B -74.44B -5.56B -5.44B -235B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | US$234.11 | -0.69% | 1,197,142 |
| 09/11/26 | US$235.74 | +0.19% | 1,206,635 |
| 06/11/26 | US$235.30 | -1.68% | 1,717,910 |
| 05/11/26 | US$239.31 | -0.50% | 1,695,458 |
| 04/11/26 | US$240.51 | +5.91% | 2,258,256 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
